Emami Analyst Review May 2026
- May 20, 2026
- Posted by: Kunal Singla
- Category: News
This Emami analyst review for May 2026 covers the key data investors need for EMAMI at its current price of Rs 595. Emami (NSE: EMAMI) is a leading Indian FMCG company with a market capitalisation of approximately Rs 10,500 crore, known for BoroPlus, Zandu Balm, Navratna Oil, and Fair and Handsome. The analyst consensus target of Rs 700 implies meaningful upside, and this Emami analyst review examines technical levels, business segments, valuation, and key risks for EMAMI through FY27.
Click Here – Get Free Investment Predictions
Emami Company Snapshot May 2026
Emami’s six power brands contribute over 65 percent of revenue. The summer portfolio (Navratna, Kesh King, Fair and Handsome) generates peak seasonal revenue. International business (MENA, SAARC, CIS) contributes 12 to 14 percent of revenue. The table below summarises the key data referenced in this Emami analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | EMAMI |
| Sector | FMCG – Personal Care and Healthcare |
| CMP (May 2026) | Rs 595 |
| 52 Week High | Rs 838 |
| 52 Week Low | Rs 548 |
| Market Cap | Rs 10,500 Crore |
| Trailing P/E | 50x |
| Analyst Consensus Target | Rs 700 |
| Bull Case Target | Rs 880 |
| Bear Case Target | Rs 540 |
Analyst Insight in This Emami Analyst Review
Senior Research Analyst Ankit Jaiswal flags Emami as a stock to watch in May 2026. At Rs 595, Ankit Jaiswal identifies key support in the Rs 559 to Rs 565 band and resistance near Rs 631. He suggests watching Emami for a potential move toward Rs 700, subject to FMCG – Personal Care and Healthcare sector momentum and Nifty 50 direction. Ankit Jaiswal’s view is one input in this Emami analyst review and does not constitute a trade recommendation.
Technical Analysis in This Emami Analyst Review
At Rs 595, EMAMI is trading within its 52-week band of Rs 548 to Rs 838. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 559 to Rs 565 band while resistance is seen in the Rs 631 to Rs 648 zone. A sustained move above Rs 631 could open the path toward the analyst consensus target of Rs 700 as outlined in this Emami analyst review.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 559 to Rs 565 – investors tracking this Emami analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for EMAMI.
- Resistance Zone: Rs 631 to Rs 648 – a sustained close above Rs 631 would be a positive breakout signal worth flagging in this Emami analyst review.
- Medium-Term Target: The analyst consensus of Rs 700 represents the base-case upside scenario in this Emami analyst review.
Business Segment Analysis
Power Brands (BoroPlus, Zandu, Navratna Oil)
This is the primary revenue and margin driver for Emami, directly supporting the earnings trajectory toward the consensus target of Rs 700.
Male Grooming and Skin Care
This segment adds scale and diversification to Emami’s business model and is a meaningful EPS contributor through FY27 and FY28.
International Business (MENA, SAARC, CIS)
This represents the medium-term growth frontier for Emami and a key re-rating catalyst over the next 12 to 24 months.
Valuation in This Emami Analyst Review
At Rs 595, Emami trades at a trailing P/E of 50x. This Emami analyst review presents three scenarios: a bull case of Rs 880 on strong earnings delivery and sector tailwinds, a base case of Rs 700 at analyst consensus, and a bear case of Rs 540 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Emami analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 880 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 700 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 540 | Earnings miss or macro headwinds |
Trade Outlook for Emami
Based on the technical and fundamental analysis in this Emami analyst review, investors might watch EMAMI near the support zone of Rs 559 to Rs 565 for potential opportunities. A flag above Rs 631 could suggest improving momentum toward Rs 700. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Emami in FY27
A well-rounded Emami analyst review must assess downside risks. Key risks for Emami include a macro slowdown affecting FMCG – Personal Care and Healthcare sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in EMAMI.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Emami Analyst Review Verdict for 2026
This Emami analyst review concludes that at Rs 595, EMAMI offers a defined risk-reward with a consensus target of Rs 700. The 52-week range of Rs 548 to Rs 838 provides context on the current entry point. Use this Emami analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on EMAMI.
Frequently Asked Questions: Emami Analyst Review 2026
What is the analyst target for Emami in 2026?
The analyst consensus target is Rs 700, with a bull case of Rs 880 and a bear case of Rs 540. This Emami analyst review recommends monitoring Q1 FY27 earnings for confirmation.
Is Emami a good investment at Rs 595?
At Rs 595 with a P/E of 50x and a consensus target of Rs 700, this Emami analyst review is constructive for medium to long-term investors in the FMCG – Personal Care and Healthcare sector. Always consult a SEBI-registered advisor before investing.
What is Emami’s 52-week high and low?
The 52-week high is Rs 838 and the 52-week low is Rs 548. At Rs 595, EMAMI is positioned within this range as detailed in this Emami analyst review.
What are the key risks for Emami?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the FMCG – Personal Care and Healthcare sector, all assessed in this Emami analyst review.
Where can I track live data for Emami?
Track Emami’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Emami analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
